To develop therapeutic strategies, in vivo detection of the early pathological changes in Parkinson’s disease is critically important. In this work, we aimed to detect early pathological changes caused by the propagation of α-synuclein in mouse brain using MRS. Recombinant α-synuclein and fibrils were prepared and injected into C57BL6 mice. 8 weeks after the injection, glutamate levels were decreased significantly compared to saline-injected control mice, which was in accordance with decreased synapsin staining in the cortex. We demonstrated that MRS can detect synaptic dysfunction caused by α-synuclein propagation in vivo.
This abstract and the presentation materials are available to members only; a login is required.